510(k) K261347

DASH Flu A/B Test by Nuclein, LLC — Product Code OCC

K261347 is an FDA 510(k) premarket notification submitted by Nuclein, LLC for the device "DASH Flu A/B Test". The FDA issued a decision of Substantially Equivalent on Oct 21, 2026. The device falls under product code OCC (Respiratory Virus Panel Nucleic Acid Assay System), a Class II device regulated under 21 CFR 866.3980. Nuclein, LLC has 1 other 510(k) clearance on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Oct 21, 2026
Date Received
Apr 24, 2026
Clearance Type
Dual Track
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Respiratory Virus Panel Nucleic Acid Assay System
Device Class
Class II
Regulation Number
866.3980
Review Panel
MI
Submission Type
510(k)

A respiratory viral panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple viral nucleic acids extracted from human respiratory specimens or viral culture. The detection and identification of a specific viral nucleic acid from individuals exhibiting signs and symptoms of respiratory infection aids in the diagnosis of respiratory viral infection when used in conjunction with other clinical and laboratory findings. The device is intended for detection and identification of a combination of the following viruses: Influenza A and Influenza B, Influenza A subtype H1 and Influenza A subtype H3, Respiratory Syncytial Virus subtype A and Respiratory Syncytial Virus subtype B, Parainfluenza 1, Parainfluenza 2, and Parainfluenza 3 virus, Human Metapneumovirus, Rhinovirus, and Adenovirus.

Source: FDA 510(k) database entry for K261347. Report a data issue: hello@regdatalab.com.